Abstract preparation/submission important requirements
- Abstracts will ONLY be accepted via the online abstract submission portal
- Abstract submissions that do not confirm to all criteria will be excluded from consideration.
- Once an abstract has been submitted you can continue to edit your abstract up until the close of abstract submissions at 11.59pm AEST Thursday 23 September 2021. After this, NO changes can be made to abstracts
- Acceptance of abstracts for oral and poster presentations will be based on the quality of the abstracts as determined by the panel of reviewers.
- There can only be one presenting author for each abstract submission/presentation.
- All successful contributed paper and poster presenters must register and pay to attend the conference. Poster presenters must register for both days.
Rules for content and structure
- Abstracts should describe work that has not previously been presented at a SHPA National Conference (publication or presentation of the work at another conference is not a criterion for exclusion).
- Author details (including institutions or affiliations) MUST NOT appear in the abstract.
NOTE: if identifying details are included, the abstract will not be considered for review.
- Abstracts must be no more than 300 words in length, including headings and references (if included) but excluding the title.
- The abstract title must be no more than 15 words in length and clearly state the nature of the work.
- No tables, graphs, pictures or diagrams are permitted in the abstract.
- Abbreviations should be avoided where possible. Any abbreviations used should be spelled out in full on first use.
- Statistical results should conform with the uniform requirements for manuscripts submitted to biomedical journals
- References are not required but may be included. References should follow the reference citation guide
NOTE: references, if included, will contribute to the total word count.
Original research (includes Clinical Research, Drug Use Evaluations, Systematic Reviews and Meta-Analysis, Pharmacoeconomic Analysis, etc.)
- Background: briefly describe the rationale for the study.
- Aim/Objective(s): a one sentence statement of the main study objective(s).
- Methods: include study design, methods, intervention.
- Results: a summary of the main results including any relevant statistical analysis.
- Discussion: the main conclusion/interpretation of the results which are supported by the data provided and a clear description of the impact of the work.
Pharmacy practice (includes Administration Projects, Health Professional Education, Medication Safety Initiatives, etc.)
- Background: briefly describe the background and rationale for service, program, problem, need, etc.
- Objective(s): describe the concept, service, role, or situation.
- Action (Method): describe the steps taken to identify and resolve a problem(s), implement change, or develop and implement the new program.
- Evaluation: describe the evaluation process of the project and results of evaluation.
- Discussion: describe the concept’s importance and impact on current and/or future practice.
- Objective: briefly describe the rationale for the case report.
- Clinical Features: relevant demographic information, medical history, presenting problems and diagnoses.
- Literature review: briefly examine current literature relating to or surrounding the case report.
- Pharmacist Interventions, Case Progress and Outcomes: these may be presented together or separately and should detail the pharmacist’s role in the case.
- Discussion: outlining lessons learnt and/or implications/importance of the case report on pharmacy practice.
Abstract submission information
All abstracts must be submitted electronically via the abstract submission portal.
- You will be asked to enter the presenting author’s contact details, affiliation information, abstract title, presentation (oral or poster), additional or all author(s).
- If submitting more than one abstract, each abstract must be submitted under the name of the presenting author.
- There can only be one presenting author for each abstract submission.
- The presenting author is invited to indicate their preference for oral or poster presentation only (or either). However, the final decision is that of the scientific program committee and will be solely determined by the quality and suitability of the abstract.
- Ensure all authors have reviewed the abstract(s) and agreed to its submission.
- You will be asked to select up to three (3) specialty practice areas that relate to your abstract from the following list:
- Aboriginal and Torres Strait Islander health
- Aid and volunteering
- Clinical trials
- Compounding services
- Critical care
- Dispensing and distribution
- Education and educational visiting
- Electronic medication management
- Emergency medicine
- General medicine
- Geriatric medicine
- Infectious diseases
- Leadership and management
- Medical specialties (other than already listed)
- Medication Safety
- Medicines information
- Mental health
- Oncology and haematology
- Paediatrics and neonatology
- Pain management
- Palliative care
- Rural and remote
- Surgery and perioperative medicine
- Transitions of care and primary care
- Women’s and newborn health